Title	Supply of Exclusive Medicines with Active Ingredients Obeticolic Acid, Cabozantinib, Tivozaniv, Axitinib, Tafamidis, Inotouzumab Ozogamicin, Lorlatinib and Isavuconazole Through Procedure N Spain
You can sign up and unlock it for free Access to Public and Private Sector Business Opportunities for 200+ Countries Subscribe now Already a member? Sign in now!
Country	Spain
Language	English
Organization	MURCIAN HEALTH SERVICE
Published Date	06.02.2024
Awarded Date	27.05.2022
Overview	Contract Award's Details : Supply of Exclusive Medicines with Active Ingredients Obeticolic Acid, Cabozantinib, Tivozaniv, Axitinib, Tafamidis, Inotouzumab Ozogamicin, Lorlatinib and Isavuconazole Through Procedure N MURCIAN HEALTH SERVICE Supply of Exclusive Medicines with Active Ingredients Obeticolic Acid, Cabozantinib, Tivozaniv, Axitinib, Tafamidis, Inotouzumab Ozogamicin, Lorlatinib and Isavuconazole Through Procedure N Document Type : Contract award notice Title : SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ÁCIDO OBETICÓLICO, CABOZANTINIB, TIVOZANIV, AXITINIB, TAFAMIDIS, INOTUZUMAB OZOGAMICINA, LORLATINIB E ISAVUCONAZOL MEDIANTE PROCEDIMIENTO N Contract No. : 1 Reference Number : CS/9999/1101023426/21/PNSP Contract Type : Supplies Estimated Value : 3602509.60 - EUR Description : SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ÁCIDO OBETICÓLICO, CABOZANTINIB, TIVOZANIV, AXITINIB, TAFAMIDIS, INOTUZUMAB OZOGAMICINA, LORLATINIB E ISAVUCONAZOL MEDIANTE PROCEDIMIENTO N 33600000 - Pharmaceutical products 33610000 - Medicinal products for the alimentary tract and metabolism 33652100 - Antineoplastic agents 33661000 - Medicinal products for the nervous system 33651200 - Antimycotics for systemic use Authority Type : Body governed by public law Type of Procedure : Negotiated without a prior call for competition Regulation : European Union Bid Type : Not applicable Doc Title : Pharmaceutical products Dispatch Date : 2022-05-23 Publish Date : 2022-05-27 Spain Contract value : 3,602,509.60 EUR Contractors : INTERCEPT PHARMA, S.L.U, INTERCEPT PHARMA, S.L, EPSEN PHARMA, S.L, EPS., EPSEN., EPS, EPS., EPSEN., EPS, EBSENA, S.L.U, PFZER, S.L.U.U.U.U.U. 18/05/2022 28/05/2022 01/01/1900 78355232 28/05/2022 MURCIAN HEALTH SERVICE Address : ADDRESS: 7. Building Habitamia 1 Town: Murcia Nuts-Code: ES62 - Region of Murcia Postal Code: 30100 Contact Point: Work Service and Hiring Phone: +34 968288035 Fax: +34 968288424 https://www.murciasalud.es antoniam.gil@carm.es Spain Spain Contract Awards Spain 18/05/2022 01/01/1900 3,602,509.60 EUR
NAICS	Other Direct Insurance (except Life Justice Regulation Justice Other Justice Regulation Direct Insurance (except Life Direct Life Other Justice
CPVS	System, storage and content management software package System, storage and content management software development services Other services Postal orders Antineoplastic agents Dates
UNSPSC	-
Regions	Europe Southern Europe Western Europe
Sectors	Civil Works Healthcare and Medicine Building Automobiles and Auto Parts Supply Postal and Courier Services Law and Legal Printing and Publishing Plastic and Rubber Electricity Construction Energy-Power and Electrical Computer Hardwares and Consumables Steel Pharmaceuticals Aviation Building Material
Contractor	INTERCEPT PHARMA, S.L.U, INTERCEPT PHARMA, S.L, EPSEN PHARMA, S.L, EPS., EPSEN., EPS, EPS., EPSEN., EPS, EBSENA, S.L.U, PFZER, S.L.U.U.U.U.U.
Contract Value	3,602,509.60 EUR
URL	Download Document
Share

Supply of Exclusive Medicines with Active Ingredients Obeticolic Acid, Cabozantinib, Tivozaniv, Axitinib, Tafamidis, Inotouzumab Ozogamicin, Lorlatinib and Isavuconazole Through Procedure N Spain

You can sign up and unlock it for free

Supply of Exclusive Medicines with Active Ingredients Obeticolic Acid, Cabozantinib, Tivozaniv, Axitinib, Tafamidis, Inotouzumab Ozogamicin, Lorlatinib and Isavuconazole Through Procedure N Spain